Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
oral antipsychotics
DRUG
2 trials
Sponsors
Janssen-Cilag International NV
, Bristol-Myers Squibb
Conditions
Schizophrenia
Phase 3
Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics
Completed
NCT01081769
Janssen-Cilag International NV
Schizophrenia
Start: 2010-02-28
End: 2013-02-28
Updated: 2015-02-18
Unknown Phase
Long-Term Real-World Safety of Cobenfy in Adults With Schizophrenia
Active, not recruiting
NCT07783373
Bristol-Myers Squibb
Schizophrenia
Start: 2026-05-01
End: 2028-04-26
Target: 3000
Updated: 2026-08-24
Related Papers
Earlier Use of Long-Acting Injectable Paliperidone Palmitate Versus Oral Antipsychotics in Patients With Schizophrenia
The Journal of Clinical Psychiatry
2023-09-21
2 citations